Invention Grant
- Patent Title: Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone
-
Application No.: US16542575Application Date: 2019-08-16
-
Publication No.: US11214827B2Publication Date: 2022-01-04
- Inventor: Mihael H. Polymeropoulos , Sandra Smieszek
- Applicant: Vanda Pharmaceuticals Inc.
- Applicant Address: US DC Washington
- Assignee: Vanda Pharmaceuticals Inc.
- Current Assignee: Vanda Pharmaceuticals Inc.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- Main IPC: C12Q1/6827
- IPC: C12Q1/6827 ; G16H50/30
Abstract:
The present invention relates to the selection of patients with enhanced antipsychotic treatment efficacy with iloperidone based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci and to treatment of such patients based upon the identification of their genetic information.
Public/Granted literature
- US20200071750A1 GENETIC MARKERS FOR ENHANCING EFFICACY OF ANTIPSYCHOTIC TREATMENT WITH ILOPERIDONE Public/Granted day:2020-03-05
Information query
